Research Report Initiated on Select Major Drug Manufacturers Equities

LONDON, UK / ACCESSWIRE / June 29, 2016 / Active Wall St announces the list of stocks for today’s research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Drug Manufacturers – Major industry. Companies recently under review include Pfizer, Merck, AbbVie, and Johnson & Johnson. See our complete report on Pfizer at:

http://www.activewallst.com/registration-3/?symbol=PFE

Today, AWS is promoting its equity research coverage. Get all of our research report free by signing up to http://www.activewallst.com/register/

The Healthcare sector has been viewed by a number of investors as a safe haven during uncertain times. Let us see how this is affecting some of the big names in the industry. Register with us now for your free membership and more research reports at:

http://www.activewallst.com/register/

Active Wall St looks at the performance of each of the companies mentioned above following yesterday’s last close and over the last few trading sessions.

Pfizer Inc. (NYSE: PFE)

New York headquartered a biopharmaceutical Company, Pfizer Inc.’s stock finished Tuesday’s session 1.89% higher at $34.44 with a total volume of 23.74 million shares traded. The Company’s shares have advanced 15.56% in the previous three months and 8.73% since the start of this year. The stock is trading 1.81% above its 50-day moving average and 8.11% above its 200-day moving average. Additionally, shares of Pfizer, which discovers, develops, manufactures, and sells healthcare products globally, have a Relative Strength Index (RSI) of 52.39. On June 20th, 2016, research firm Jefferies reiterated its ‘Buy’ rating with a decrease of the target price to $40 a share from $42 a share for the Company’s stock.

Merck & Co. Inc. (NYSE: MRK)

On Tuesday, shares in Kenilworth, New Jersey headquartered Merck & Co. Inc. recorded a trading volume of 12.74 million shares, which was above their three months average volume of 8.73 million shares. The stock ended the session 0.49% higher at $55.58. The Company’s shares have advanced 5.29% in the previous three months and 7.01% on an YTD basis. The stock is trading 0.18% above its 50-day moving average and 6.23% above its 200-day moving average. Moreover, shares of Merck & Co., which provides health care solutions globally, have an RSI of 47.20. Sign up for your research report on MRK at:

http://www.activewallst.com/registration-3/?symbol=MRK

AbbVie Inc. (NYSE: ABBV)

Shares in North Chicago, Illinois-based AbbVie Inc. closed the day 2.23% higher at $59.99. The stock recorded a trading volume of 9.89 million shares, which was higher than its three months average volume of 8.32 million shares. The Company’s shares have gained 6.26% over the previous three months and 3.31% on an YTD basis. The stock is trading 4.64% above its 200-day moving average. Additionally, shares of AbbVie, which discovers, develops, manufactures, and sells pharmaceutical products globally, have an RSI of 46.12. On June 08th, 2016, research firm Morgan Stanley downgraded the Company’s stock rating from ‘Overweight’ to ‘Equal-Weight’. Register for free and download the research report on ABBV at:

http://www.activewallst.com/registration-3/?symbol=ABBV

Johnson & Johnson (NYSE: JNJ)

At the close, shares in New Brunswick, New Jersey-based Johnson & Johnson finished at $118.23, gaining 1.44%. The stock recorded a trading volume of 10.07 million shares, which was above its three months average volume of 7.04 million shares. The Company’s shares have advanced 4.57% in the last one month, 9.26% in the previous three months, and 16.76% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 3.87% and 14.08%, respectively. Furthermore, shares of Johnson & Johnson, which together with its subsidiaries, research and develop, manufacture, and sell various products in the health care field globally, have an RSI of 64.81. The research report on JNJ is available for free at:

http://www.activewallst.com/registration-3/?symbol=JNJ

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated directly or indirectly for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 441780